CRI Stock Overview
Operates in the space and science industry in Poland. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Creotech Instruments S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł155.00 |
52 Week High | zł248.00 |
52 Week Low | zł115.50 |
Beta | -0.048 |
11 Month Change | 20.16% |
3 Month Change | -33.76% |
1 Year Change | -24.39% |
33 Year Change | 46.23% |
5 Year Change | n/a |
Change since IPO | 109.88% |
Recent News & Updates
Shareholder Returns
CRI | PL Aerospace & Defense | PL Market | |
---|---|---|---|
7D | -2.5% | -3.3% | -3.6% |
1Y | -24.4% | 26.1% | -0.01% |
Return vs Industry: CRI underperformed the Polish Aerospace & Defense industry which returned 25.4% over the past year.
Return vs Market: CRI underperformed the Polish Market which returned 1.1% over the past year.
Price Volatility
CRI volatility | |
---|---|
CRI Average Weekly Movement | 10.1% |
Aerospace & Defense Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in PL Market | 8.6% |
10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: CRI's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: CRI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 229 | Grzegorz Brona | www.creotech.pl |
Creotech Instruments S.A. operates in the space and science industry in Poland. The company produces aircrafts, spacecrafts, electronic components, computers and peripheral devices, telecommunications equipment, and related machines. It also manufactures measuring, control, and navigation instruments and devices; produces and distributes electricity; and produces control apparatus.
Creotech Instruments S.A. Fundamentals Summary
CRI fundamental statistics | |
---|---|
Market cap | zł368.80m |
Earnings (TTM) | -zł16.22m |
Revenue (TTM) | zł41.33m |
8.9x
P/S Ratio-22.7x
P/E RatioIs CRI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CRI income statement (TTM) | |
---|---|
Revenue | zł41.33m |
Cost of Revenue | zł9.09m |
Gross Profit | zł32.25m |
Other Expenses | zł48.47m |
Earnings | -zł16.22m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 27, 2024
Earnings per share (EPS) | -6.82 |
Gross Margin | 78.01% |
Net Profit Margin | -39.25% |
Debt/Equity Ratio | 0% |
How did CRI perform over the long term?
See historical performance and comparison